The poster presentation will highlight three partner-published studies using the Tropis ® Intradermal ... The International mRNA Health Conference (Conference Days, 12-14 November 2024) is the premier ...

Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors highli ...

Achieved $49.3 million in OGSIVEO ® (nirogacestat) net product revenue in the third quarter – – Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors ...

Zale Peart ’25 presents his poster, “Rethinking Rail: A Sustainable Future for American Transportation,” during the sixth ...